Literature DB >> 2506273

Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma.

E Cillari1, M Dieli, E Maltese, S Milano, A Salerno, F Y Liew.   

Abstract

Peritoneal cells from highly susceptible BALB/c mice were infected with Leishmania major and cultured for various times in vitro. The culture supernatants contained significant levels of IL-1 which were consistently higher than those in the cell cultures stimulated with an optimal concentration of LPS. This finding extends to a macrophage cell line, P388D1, and peritoneal exudate cells stimulated with starch in vivo. However, the level of IL-1 produced was significantly reduced when the cells were preincubated with a lymphokine preparation (supernatant of Con A-stimulated rat spleen cells). The level of IL-1 produced seems to be directly correlated with the degree of parasitization of the macrophages. A similar and dose-dependent reduction in IL-1 production by infected macrophages could also be obtained when the cells were preincubated with IFN-gamma. This finding is in direct contrast to that of visceral leishmaniasis in which peritoneal macrophages from BALB/c mice infected with Leishmania donovani not only fail to produce IL-1 but also lose the capacity to produce IL-1. This apparent discrepancy is discussed in terms of a possible difference in the induction of cell-mediated immunity between the two leishmanial diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506273

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  An in vitro model for infection with Leishmania major that mimics the immune response in mice.

Authors:  M B Soares; J R David; R G Titus
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.

Authors:  N E Reiner; W Ng; C B Wilson; W R McMaster; S K Burchett
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution.

Authors:  W H Boom; L Liebster; A K Abbas; R G Titus
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro.

Authors:  E Cillari; F Arcoleo; M Dieli; R D'Agostino; G Gromo; F Leoni; S Milano
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Keratinocytes determine Th1 immunity during early experimental leishmaniasis.

Authors:  Jan M Ehrchen; Kirsten Roebrock; Dirk Foell; Nadine Nippe; Esther von Stebut; Johannes M Weiss; Niels-Arne Münck; Dorothee Viemann; Georg Varga; Carsten Müller-Tidow; Hans-Joachim Schuberth; Johannes Roth; Cord Sunderkötter
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

Review 6.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice.

Authors:  Carole Dumas; Anthony Muyombwe; Gaétan Roy; Claudine Matte; Marc Ouellette; Martin Olivier; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis.

Authors:  Jiaxiang Ji; Jiaren Sun; Lynn Soong
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction.

Authors:  G Cáceres-Dittmar; F J Tapia; M A Sánchez; M Yamamura; K Uyemura; R L Modlin; B R Bloom; J Convit
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

10.  Cell-mediated responses of immunized vervet monkeys to defined Leishmania T-cell epitopes.

Authors:  A J Curry; A Jardim; J O Olobo; R W Olafson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.